COLD-FIX Trademark

Trademark Overview


On Thursday, January 26, 2017, a trademark application was filed for COLD-FIX with the United States Patent and Trademark Office. The USPTO has given the COLD-FIX trademark a serial number of 79221633. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Friday, May 8, 2020. This trademark is owned by Mapix S.à.r.l. The COLD-FIX trademark is filed in the Pharmaceutical Products category with the following description:

Sanitary preparations for medical purposes; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses such as varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, and adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infectious diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial...
cold-fix

General Information


Serial Number79221633
Word MarkCOLD-FIX
Filing DateThursday, January 26, 2017
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateFriday, May 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements


Goods and ServicesSanitary preparations for medical purposes; disinfectants; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses such as varicella and infectious mononucleosis; pharmaceutical preparations for prevention and treatment of enterovirus, rotavirus, coronavirus, and adenoviral diseases; pharmaceutical preparations for prevention and treatment of diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; antibody-based pharmaceutical preparations for the treatment of infectious diseases; antibody-based pharmaceutical preparations, namely, pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal infections, herpes infections, including herpes type I and II, genital herpes, labial herpes and other diseases caused by herpes viruses such as varicella and infectious mononucleosis; antibody-based pharmaceutical preparations for the prevention and treatment of enterovirus, rotavirus, coronaviruses, and adenoviral diseases; antibody-based pharmaceutical preparations to prevent and treat diseases caused by tick-borne encephalitis virus, calicivirus, and respiratory viruses; drugs for the treatment of AIDS/HIV infection; antibody-based pharmaceutical preparations for the treatment of AIDS/HIV infection; pharmaceutical preparations for the treatment of viral hepatitis; antibody-based pharmaceutical preparations for the treatment of viral hepatitis; pharmaceutical preparations for the treatment of influenza; antibody-based drugs pharmaceutical preparations for the treatment of influenza; disinfectants for hygiene purposes, including disinfectants fighting microorganisms which cause infectious disease in man; immunomodulators; anti-mutagenic pharmaceutical preparations for the prevention and treatment of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, May 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMapix S.à.r.l
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLU

Party NameMapix S.à.r.l
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLU

Trademark Events


Event DateEvent Description
Sunday, May 30, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 10, 2021FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 8, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, May 8, 2020ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Friday, May 8, 2020ABANDONMENT - AFTER INTER PARTES DECISION
Friday, May 8, 2020OPPOSITION TERMINATED NO. 999999
Friday, May 8, 2020OPPOSITION DISMISSED NO. 999999
Tuesday, April 21, 2020LIMITATION FROM THE IB EXAMINED AND ENTERED
Friday, February 7, 2020LIMITATION OF GOODS RECEIVED FROM IB
Friday, May 10, 2019NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 24, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 24, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, June 8, 2018REFUSAL PROCESSED BY IB
Thursday, May 17, 2018OPPOSITION INSTITUTED NO. 999999
Wednesday, May 16, 2018OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Wednesday, May 16, 2018OPPOSITION NOTICE (IB REFUSAL) CREATED
Friday, May 4, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, May 3, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 6, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, February 1, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, February 1, 2018FINAL REFUSAL E-MAILED
Thursday, February 1, 2018FINAL REFUSAL WRITTEN
Friday, January 19, 2018REFUSAL PROCESSED BY IB
Thursday, January 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 10, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 10, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 30, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, December 30, 2017REFUSAL PROCESSED BY MPU
Tuesday, December 19, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 15, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, December 14, 2017NON-FINAL ACTION WRITTEN
Tuesday, December 12, 2017APPLICATION FILING RECEIPT MAILED
Thursday, December 7, 2017ASSIGNED TO EXAMINER
Thursday, December 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 23, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB